Evidence map›Paper›PMID 38568977›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Complexin has a dual synaptic function as checkpoint protein in vesicle priming and as a promoter of vesicle fusion.

Francisco José López-Murcia, Kun-Han Lin, Manon M M Berns, Mrinalini Ranjan, Noa Lipstein, Erwin Neher, Nils Brose, Kerstin Reim, Holger Taschenberger

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Postsynaptic Complexin Mediates Constitutive Exocytosis of Nicotinic Acetylcholine Receptor.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Review
  4. Article
  5. Role of complexin 2 in the regulation of hormone secretion from the islet of Langerhans.American journal of physiology. Endocrinology and metabolism · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Francisco José López-MurciaDepartment of Molecular Neurobiology, Max Planck Institute for Multidisciplinary Sciences, Göttingen 37075, Germany.ORCID 0000-0002-0778-4106
Kun-Han LinLaboratory of Membrane Biophysics, Max Planck Institute for Multidisciplinary Sciences, Göttingen 37077, Germany.
Manon M M BernsDepartment of Molecular Neurobiology, Max Planck Institute for Multidisciplinary Sciences, Göttingen 37075, Germany.ORCID 0000-0003-2998-4202
Mrinalini RanjanDepartment of Molecular Neurobiology, Max Planck Institute for Multidisciplinary Sciences, Göttingen 37075, Germany.ORCID 0000-0003-4310-3811
Noa LipsteinDepartment of Molecular Neurobiology, Max Planck Institute for Multidisciplinary Sciences, Göttingen 37075, Germany.ORCID 0000-0002-0755-5899
Erwin NeherLaboratory of Membrane Biophysics, Max Planck Institute for Multidisciplinary Sciences, Göttingen 37077, Germany.ORCID 0000-0002-9758-7922
Nils BroseDepartment of Molecular Neurobiology, Max Planck Institute for Multidisciplinary Sciences, Göttingen 37075, Germany.
Kerstin ReimDepartment of Molecular Neurobiology, Max Planck Institute for Multidisciplinary Sciences, Göttingen 37075, Germany.ORCID 0000-0002-5448-8377
Holger TaschenbergerDepartment of Molecular Neurobiology, Max Planck Institute for Multidisciplinary Sciences, Göttingen 37075, Germany.ORCID 0000-0003-3186-3231

Funding

Alexander von Humboldt-Stiftung (AvH) postdoctoral fellowshipDeutsche Forschungsgemeinschaft (DFG) Cluster of Excellence EXC 2067Deutsche Forschungsgemeinschaft (DFG) CRC 1286Deutsche Forschungsgemeinschaft (DFG) Excellence Strategy - EXC-2049-390688087MEC | Agencia Estatal de Investigación (AEI) PID2022-141685NA-I00
6 · The paper itself

Abstract

The presynaptic SNARE-complex regulator complexin (Cplx) enhances the fusogenicity of primed synaptic vesicles (SVs). Consequently, Cplx deletion impairs action potential-evoked transmitter release. Conversely, though, Cplx loss enhances spontaneous and delayed asynchronous release at certain synapse types. Using electrophysiology and kinetic modeling, we show that such seemingly contradictory transmitter release phenotypes seen upon Cplx deletion can be explained by an additional of Cplx in the control of SV priming, where its ablation facilitates the generation of a "faulty" SV fusion apparatus. Supporting this notion, a sequential two-step priming scheme, featuring reduced vesicle fusogenicity and increased transition rates into the faulty primed state, reproduces all aberrations of transmitter release modes and short-term synaptic plasticity seen upon Cplx loss. Accordingly, we propose a dual presynaptic function for the SNARE-complex interactor Cplx, one as a "checkpoint" protein that guarantees the proper assembly of the fusion machinery during vesicle priming, and one in boosting vesicle fusogenicity.

Indexed as

SynapsesSynaptic VesiclesAction PotentialsNerve Tissue ProteinsSNARE ProteinsSynaptic TransmissionNerve Tissue ProteinsSNARE Proteinscalyx of Heldnumerical simulationshort-term plasticitysynaptic transmissionsynaptic vesicle priming

Identifiers

PMID38568977
PMCPMC11009659

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.